---
title: "Pre-market hot trades in US stocks: Regentis Biomaterials pre-market up 7.14%, active funds but no positive news"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293217893.md"
description: "Regentis Biomaterials pre-market up 7.14%; Baiya pre-market up 81.12%; K Wave Media pre-market up 47.38%; Zhengye Biotechnology pre-market up 40.00%"
datetime: "2026-07-20T13:01:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293217893.md)
  - [en](https://longbridge.com/en/news/293217893.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293217893.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Regentis Biomaterials pre-market up 7.14%, active funds but no positive news

**Popular Pre-Market Trades in US Stocks**

Regentis Biomaterials, up 7.14% in pre-market, has no significant news recently. Trading is active with clear capital flow, and considering sector and industry trends, the stock shows notable volatility, with specific reasons needing further observation.

**Top Gainers in Pre-Market US Stocks**

Baiya is up 81.12% in pre-market. Based on recent news,

1.  On July 17, GrowHub announced a $400 million merger agreement with EnChem, causing the stock price to surge by 86%. This news boosted market confidence in the related industry, driving Baiya's stock price up.

2.  On July 17, Netflix released its second-quarter earnings report, which was mixed, and provided a weak third-quarter guidance, leading to a 9.6% drop in its stock price. This news raised concerns in the tech sector, indirectly affecting Baiya's stock price volatility.

3.  On July 17, Jasper Therapeutics announced a merger with Kira Pharmaceuticals, resulting in a 13.4% drop in its stock price. This news negatively impacted the biotech sector, affecting Baiya as a company in the same sector. Market sentiment towards the tech and biotech sectors is quite volatile.

K Wave Media is up 47.38% in pre-market. Based on recent key news:

1.  On July 20, K Wave Media Ltd. released important content, significantly boosting its stock price. The company published original content via GlobeNewswire, showing a positive market response, with the stock price rising 47.38% in pre-market. Source: Public Technologies

2.  There are no other recent news items. Market sentiment is positive, with clear capital inflow.

Zhengye Biotechnology is up 40.00% in pre-market, with no significant news recently. Trading is active with clear capital flow, and considering sector and industry trends, the stock shows notable volatility, with specific reasons needing further observation

### Related Stocks

- [RGNT.US](https://longbridge.com/en/quote/RGNT.US.md)
- [BIYA.US](https://longbridge.com/en/quote/BIYA.US.md)
- [KWM.US](https://longbridge.com/en/quote/KWM.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)

## Related News & Research

- [Regentis Biomaterials (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks](https://longbridge.com/en/news/296129477.md)
- [Global Brain leads investment in cancer detection startup MiRNDa](https://longbridge.com/en/news/296842692.md)
- [McDonald’s Just Started Selling Energy Drinks. How to Play MCD Stock Here.](https://longbridge.com/en/news/296685013.md)
- [Is AbbVie (ABBV) Fairly Valued As New Lung Cancer Data Impresses?](https://longbridge.com/en/news/296816441.md)
- [WealthShield Partners LLC Makes New Investment in Entergy Corporation $ETR](https://longbridge.com/en/news/296699070.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**